Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Serum Antibodies to Blood Group A Predict Survival on PROSTVAC-VF

(2013) C. T. Campbell et al.   CLINICAL CANCER RESEARCH

Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53

(2013) Ruey-Shyang Soong et al.   PLoS One

Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?

(2013) Edward Cha et al.   Cancer Medicine

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

(2012) Saskia J. A. M. Santegoets et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Multicolor flow cytometry analysis of the proliferations of T-lymphocyte subsetsin vitroby EdU incorporation

(2012) Yanli Sun et al.   CYTOMETRY PART A

Induction of tumoricidal function in CD4+T cells is associated with concomitant memory and terminally differentiated phenotype

(2012) Daniel Hirschhorn-Cymerman et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect

(2012) Mariola Fotin-Mleczek et al.   JOURNAL OF GENE MEDICINE

RNA-based vaccines

(2012) Jeffrey B. Ulmer et al.   VACCINE

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer

(2012) Thomas Gardner et al.   Human Vaccines & Immunotherapeutics

Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles

(2011) Carlee E. Ashley et al.   ACS Nano

A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae

(2011) Shipeng Sun et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Virus-like particles induce robust human T-helper cell responses

(2011) Marion Braun et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

mRNA: delivering an antitumor message?

(2011) Sandra Van Lint et al.   Immunotherapy

An Artificial PAP Gene Breaks Self-tolerance and Promotes Tumor Regression in the TRAMP Model for Prostate Carcinoma

(2011) Elmar Spies et al.   MOLECULAR THERAPY

Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA

(2011) Federico Perche et al.   Nanomedicine-Nanotechnology Biology and Medicine

A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2

(2011) Ebenezer Tumban et al.   PLoS One

Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses

(2011) Zoe Hunter et al.   VACCINE

Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides

(2011) Jerri C Caldeira et al.   JOURNAL OF NANOBIOTECHNOLOGY

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase

(2010) Brian M. Olson et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

(2010) S. Kreiter et al.   CANCER RESEARCH

DNA vaccines for the treatment of prostate cancer

(2010) Sheeba Alam et al.   Expert Review of Vaccines

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer

(2010) P Castelo-Branco et al.   GENE THERAPY

DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer

(2010) Jordan T. Becker et al.   JOURNAL OF IMMUNOTHERAPY

Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

(2010) Susanne M Rittig et al.   MOLECULAR THERAPY

Armored Long RNA Controls or Standards for Branched DNA Assay for Detection of Human Immunodeficiency Virus Type 1

(2009) S. Zhan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The use of Armored RNA as a multi-purpose internal control for RT-PCR

(2008) Jeffery Stevenson et al.   JOURNAL OF VIROLOGICAL METHODS